Public Meeting on Patient-Generated Health Data - May 4, 2021

U.S. Food and Drug Administration sent this bulletin at 03/19/2021 11:06 AM EDT

If your email program has trouble displaying this email, view as a webpage.
US Food and Drug Administration

Virtual Public Meeting: Patient-Generated Health Data Throughout the Total Product Life Cycle of Medical Devices

The U.S. Food and Drug Administration (FDA) is announcing a virtual public meeting, Patient-Generated Health Data Throughout the Total Product Life Cycle of Medical Devices.

The purpose of this public meeting is to discuss patient-generated health data (PGHD) and its potential impact across the health care system. PGHD includes health-related data that is created, recorded, or gathered by or from patients, such as health and treatment history, biometric data, symptoms, and lifestyle habits.

Topics include: Sources of PGHD, data quality measures, interoperability, and potential impacts of the data in regulatory and health care settings.

  • Meeting Date: Tuesday, May 4, 2021, 10:00 a.m. - 4:00 p.m. EDT
  • Location: This public meeting will be webcast.
  • Registration Deadline: Monday, May 3, 2021 by 4:00 p.m. EDT

Read More

Other Deadlines

  • By May 3, 2021: Request special accommodations for the meeting.

Questions?

If you have questions about this virtual public meeting, contact Christina Webber Christina.Webber@fda.hhs.gov.